Personal Genomics takes PacBio dispute to Chinese court
22-05-2020
Illumina buys rival Pacific Biosciences for $1.2bn
02-11-2018
Vchal / Shutterstock.com
In its suit, filed at the US District Court for the District of Delaware on Thursday, September 26, PGI accused Pacific Biosciences of infringing US patent 7,767,441 through the sale of its nucleic acid sequencing platform Sequel System.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Pacific Biosciences, genetics, genetic sequencing, Personal Genomics Taiwan, patent infringement, illumina, gene-sequencing
